<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font24 { font-size : 24; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font24">and </span>
   <span class="font22">plasma </span>
   <span class="font21">convalescent </span>
   <span class="font20">for </span>
   <span class="font17">with </span>
   <span class="font16">therapy </span>
   <span class="font15">COVID- </span>
   <span class="font15">patients </span>
   <span class="font14">[]. </span>
   <span class="font14">{background </span>
   <span class="font13">study </span>
   <span class="font13">that </span>
   <span class="font13">disease </span>
   <span class="font13">have </span>
   <span class="font13">severe </span>
   <span class="font13">clinical </span>
   <span class="font13">margin </span>
   <span class="font13">neutralizing </span>
   <span class="font13">should </span>
   <span class="font12">The </span>
   <span class="font12">was </span>
   <span class="font12">{border-style </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">days </span>
   <span class="font12">treatment </span>
   <span class="font12">antibody </span>
   <span class="font12">are </span>
   <span class="font12">coronavirus </span>
   <span class="font12">not </span>
   <span class="font12">JYC. </span>
   <span class="font12">been </span>
   <span class="font12">respiratory </span>
   <span class="font12">studies </span>
   <span class="font11">from </span>
   <span class="font11">viral </span>
   <span class="font11">were </span>
   <span class="font11">acute </span>
   <span class="font11">may </span>
   <span class="font11">showed </span>
   <span class="font11">titers </span>
   <span class="font11">use </span>
   <span class="font11">who </span>
   <span class="font11">SARS-CoV- </span>
   <span class="font11">antibodies </span>
   <span class="font11">has </span>
   <span class="font11">virus </span>
   <span class="font11">However, </span>
   <span class="font11">Infect </span>
   <span class="font11">after </span>
   <span class="font11">al., </span>
   <span class="font11">donor </span>
   <span class="font11">donors </span>
   <span class="font11">effects </span>
   <span class="font11">efficacy </span>
   <span class="font11">such </span>
   <span class="font11">within </span>
   <span class="font11">China </span>
   <span class="font11">Nonrandomized, </span>
   <span class="font11">blood </span>
   <span class="font11">group </span>
   <span class="font11">including </span>
   <span class="font11">life-threatening </span>
   <span class="font11">more </span>
   <span class="font11">non-controlled </span>
   <span class="font11">px; </span>
   <span class="font11">safety </span>
   <span class="font11">time </span>
   <span class="font11">{font-family </span>
   <span class="font11">COVID-, </span>
   <span class="font11">TRALI </span>
   <span class="font11">adverse </span>
   <span class="font11">antibodies, </span>
   <span class="font11">diseases </span>
   <span class="font11">effectiveness </span>
   <span class="font11">font-size </span>
   <span class="font11">improved </span>
   <span class="font11">improvement </span>
   <span class="font11">intervention </span>
   <span class="font11">performed </span>
   <span class="font11">suggested </span>
   <span class="font11">syndrome </span>
   <span class="font11">transfusion </span>
   <span class="font11">used </span>
   <span class="font10">Convalescent </span>
   <span class="font10">Dis </span>
   <span class="font10">Korean </span>
   <span class="font10">Med </span>
   <span class="font10">antiviral </span>
   <span class="font10">can </span>
   <span class="font10">double; </span>
   <span class="font10">events </span>
   <span class="font10">historical </span>
   <span class="font10">laboratory </span>
   <span class="font10">mortality </span>
   <span class="font10">neutralization </span>
   <span class="font10">randomized </span>
   <span class="font10">than </span>
   <span class="font10">titer </span>
   <span class="font10">trials </span>
   <span class="font10">ADE </span>
   <span class="font10">August </span>
   <span class="font10">CI: </span>
   <span class="font10">COVID-. </span>
   <span class="font10">During </span>
   <span class="font10">Ebola </span>
   <span class="font10">IgG </span>
   <span class="font10">None </span>
   <span class="font10">Society </span>
   <span class="font10">TACO </span>
   <span class="font10">among </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">collection </span>
   <span class="font10">considered </span>
   <span class="font10">control </span>
   <span class="font10">controlled </span>
   <span class="font10">died </span>
   <span class="font10">evidence </span>
   <span class="font10">ill </span>
   <span class="font10">infectious </span>
   <span class="font10">influenza </span>
   <span class="font10">least </span>
   <span class="font10">precedents </span>
   <span class="font10">provide </span>
   <span class="font10">reported </span>
   <span class="font10">review </span>
   <span class="font10">solid; </span>
   <span class="font10">test </span>
   <span class="font10">those </span>
   <span class="font10">transfusion-related </span>
   <span class="font10">treating </span>
   <span class="font10">trial </span>
   <span class="font10">which </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(.%) </span>
   <span class="font10">Clin </span>
   <span class="font10">Clinical </span>
   <span class="font10">Engl </span>
   <span class="font10">Korea </span>
   <span class="font10">Plasma </span>
   <span class="font10">addition </span>
   <span class="font10">ahead </span>
   <span class="font10">assays </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">bold </span>
   <span class="font10">circulatory </span>
   <span class="font10">collab: </span>
   <span class="font10">compared </span>
   <span class="font10">conducted </span>
   <span class="font10">courier; </span>
   <span class="font10">critically </span>
   <span class="font10">development </span>
   <span class="font10">donation </span>
   <span class="font10">early </span>
   <span class="font10">eligibility </span>
   <span class="font10">em; </span>
   <span class="font10">evaluated </span>
   <span class="font10">first </span>
   <span class="font10">given </span>
   <span class="font10">had </span>
   <span class="font10">immunoglobulin </span>
   <span class="font10">infection </span>
   <span class="font10">lack </span>
   <span class="font10">lung </span>
   <span class="font10">participants </span>
   <span class="font10">patients. </span>
   <span class="font10">plasma. </span>
   <span class="font10">print] </span>
   <span class="font10">pt;} </span>
   <span class="font10">recent </span>
   <span class="font10">recovered </span>
   <span class="font10">reduction </span>
   <span class="font10">response </span>
   <span class="font10">results </span>
   <span class="font10">several </span>
   <span class="font10">therapeutic </span>
   <span class="font10">this </span>
  </p>
 </body>
</html>
